Related references
Note: Only part of the references are listed.BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats
Zhangqiong Huang et al.
FOOD AND CHEMICAL TOXICOLOGY (2021)
Scientific and Regulatory Policy Committee Points to Consider*: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists
Rani S. Sellers et al.
TOXICOLOGIC PATHOLOGY (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Reconstruction of the full transmission dynamics of COVID-19 in Wuhan
Xingjie Hao et al.
NATURE (2020)
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
Jawad Al-Kassmy et al.
VIRUSES-BASEL (2020)
Evaluation of Rat Acute Phase Proteins as Inflammatory Biomarkers for Vaccine Nonclinical Safety Studies
William J. Reagan et al.
TOXICOLOGIC PATHOLOGY (2020)
Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs
Cindy Bernelin-Cottet et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Use of Severity Grades to Characterize Histopathologic Changes
Kenneth A. Schafer et al.
TOXICOLOGIC PATHOLOGY (2018)
Delineating the Cellular Mechanisms Associated with Skin Electroporation
Katherine Schultheis et al.
HUMAN GENE THERAPY METHODS (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques
Biliana Todorova et al.
SCIENTIFIC REPORTS (2017)
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
John J. Suschak et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Electroporation-based applications in biotechnology
Tadej Kotnik et al.
TRENDS IN BIOTECHNOLOGY (2015)
Large Unstained Cells: A Potentially Valuable Parameter in the Assessment of Immune Activation Levels in HIV Infection
Naadira Vanker et al.
ACTA HAEMATOLOGICA (2014)
Dual therapeutic benefit of electroporation-mediated DNA vaccination in vivo Enhanced gene transfer and adjuvant activity
Christophe Y. Calvet et al.
ONCOIMMUNOLOGY (2014)
Cancer vaccination by electro-gene-transfer
Luigi Aurisicchio et al.
EXPERT REVIEW OF VACCINES (2013)
Electroporation as a Method to Induce Myofiber Regeneration and Increase the Engraftment of Myogenic Cells in Skeletal Muscles of Primates
Daniel Skuk et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Overview of global regulatory toxicology requirements for vaccines and adjuvants
Yuansheng Sun et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Study designs for the nonclinical safety testing of new vaccine products
Roy Forster
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation
Karen E. Dolter et al.
VACCINE (2011)
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo Electroporation
Jinyan Liu et al.
JOURNAL OF VIROLOGY (2008)
Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles
MJ Molnar et al.
MOLECULAR THERAPY (2004)
Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines
S Babiuk et al.
JOURNAL OF BIOTECHNOLOGY (2004)
Share Paper
